Dr Suzanne El-attar Evans, MD | |
1355 N 205th St, Shoreline, WA 98133-3215 | |
(206) 542-5656 | |
(206) 520-1899 |
Full Name | Dr Suzanne El-attar Evans |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 31 Years |
Location | 1355 N 205th St, Shoreline, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649225301 | NPI | - | NPPES |
1649225301 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD00033865 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Swedish Edmonds Hospital | Edmonds, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Association Of University Physicians | 0446162697 | 3009 |
News Archive
Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, today announced financial results for the first quarter ended March 31, 2014.
Now, the researchers from the Massachusetts Institute of Technology (MIT) have identified specific types of cells that are targets of the SARS-CoV-2 that causes the COVID-19 pandemic. The findings of the study published in the journal Cell may help in developing novel therapeutics to combat the deadly viral infection.
Managing weight, blood pressure and cholesterol in children may help protect brain function in later life, according to new research published today in the American Heart Association's flagship journal Circulation.
China-Biotics, Inc., the leading developer, manufacturer and distributor of probiotics products in China, today announced that it has submitted two new patent applications to the State Bureau of Intellect Property.
› Verified 4 days ago
Entity Name | The Association Of University Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, today announced financial results for the first quarter ended March 31, 2014.
Now, the researchers from the Massachusetts Institute of Technology (MIT) have identified specific types of cells that are targets of the SARS-CoV-2 that causes the COVID-19 pandemic. The findings of the study published in the journal Cell may help in developing novel therapeutics to combat the deadly viral infection.
Managing weight, blood pressure and cholesterol in children may help protect brain function in later life, according to new research published today in the American Heart Association's flagship journal Circulation.
China-Biotics, Inc., the leading developer, manufacturer and distributor of probiotics products in China, today announced that it has submitted two new patent applications to the State Bureau of Intellect Property.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Suzanne El-attar Evans, MD Po Box 50095, Seattle, WA 98145-5095 Ph: (206) 543-6420 | Dr Suzanne El-attar Evans, MD 1355 N 205th St, Shoreline, WA 98133-3215 Ph: (206) 542-5656 |
News Archive
Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, today announced financial results for the first quarter ended March 31, 2014.
Now, the researchers from the Massachusetts Institute of Technology (MIT) have identified specific types of cells that are targets of the SARS-CoV-2 that causes the COVID-19 pandemic. The findings of the study published in the journal Cell may help in developing novel therapeutics to combat the deadly viral infection.
Managing weight, blood pressure and cholesterol in children may help protect brain function in later life, according to new research published today in the American Heart Association's flagship journal Circulation.
China-Biotics, Inc., the leading developer, manufacturer and distributor of probiotics products in China, today announced that it has submitted two new patent applications to the State Bureau of Intellect Property.
› Verified 4 days ago
Dr. Shannah Marie Hewitt, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 N 175th St, Shoreline, WA 98133 Phone: 206-401-3200 Fax: 206-401-3201 | |
Elizabeth B O'kane, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1355 N 205th St, Shoreline, WA 98133 Phone: 206-542-5656 | |
Martin D Levine, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 15214 Aurora Ave N, Shoreline, WA 98133 Phone: 206-518-9021 Fax: 206-299-0987 | |
Tamara Zina Anne Atkins, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1355 N 205th Street, Shoreline, WA 98133 Phone: 206-542-5656 | |
David L Chan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 604 Nw Richmond Beach Rd, Shoreline, WA 98177 Phone: 206-533-2900 Fax: 206-533-2901 | |
Dr. Allison Grace Cummings, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1355 N 205th St, Shoreline, WA 98133 Phone: 206-520-5000 | |
Seth Charles Bagan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1355 N. 205th St., Shoreline, WA 98133 Phone: 617-414-2080 Fax: 617-414-2090 |